HART MICHAEL E 4/A
4/A · ALLOS THERAPEUTICS INC · Filed Jan 20, 2004
Insider Transaction Report
Form 4/AAmended
HART MICHAEL E
DirectorChief Executive Officer
Transactions
- Award
Stock Options (Right to buy)
2004-01-19+40,000→ 40,000 totalExercise: $3.77From: 2004-02-19Exp: 2014-01-19→ Common Stock (40,000 underlying)
Holdings
- 240,250
Stock Options (Right to buy)
Exercise: $0.56From: 2000-11-15Exp: 2009-12-02→ Common Stock (240,250 underlying) - 70,000
Stock Options (Right to buy)
Exercise: $3.20From: 2003-07-03Exp: 2013-06-03→ Common Stock (70,000 underlying) - 9,500
Stock Options (Right to buy)
Exercise: $4.50From: 2002-07-17Exp: 2011-07-17→ Common Stock (9,500 underlying) - 62,000
Stock Options (Right to buy)
Exercise: $2.42From: 2007-01-12Exp: 2010-01-12→ Common Stock (62,000 underlying) - 250,000
Stock Options (Right to buy)
Exercise: $5.14From: 2003-01-17Exp: 2012-01-17→ Common Stock (250,000 underlying) - 100,000
Stock Options (Right to buy)
Exercise: $5.74From: 2002-11-30Exp: 2011-11-30→ Common Stock (100,000 underlying) - 55,000
Stock Options (Right to buy)
Exercise: $7.08From: 2006-01-17Exp: 2013-01-17→ Common Stock (55,000 underlying) - 2,000
Common Stock
- 28,500
Stock Options (Right to buy)
Exercise: $6.38From: 2002-03-01Exp: 2011-03-01→ Common Stock (28,500 underlying)
Footnotes (1)
- [F1]Stock options vest according to the following schedule: One fourth (1/4) of the total number of shares subject to this option shall vest 12 months after the vesting commencement date and an additional one-forty-eigths (1/48) of the total number of shares subject to the option become exercisable each one-month-period thereafter, until all such shares are exercisable.